Experts say the FDA "moved the goalposts" on Moderna, creating "a destructive precedent that will undermine the future of ...

In an interview, Moderna President Stephen Hoge took questions on an FDA decision on the biotech's mRNA flu vaccine, as well ...

This week on "The Readout LOUD," everything you need to know about the FDA's controversial decision to block the review of ...

Public Citizen contends that Novo Nordisk and Eli Lilly's obesity drugs are straining budgets so much that generics should be ...

Prasad changed jobs but his conservative regulatory doctrine remains the same, particularly for cell and gene therapies. The ...

Some pharmaceutical companies not targeted by President Trump for agreements to lower U.S. drug pricing aim to craft their ...

Talkiatry, a virtual psychiatry company, announced Thursday it raised $210 million as it looks to build on its ...

BridgeBio Pharma’s experimental drug for the most common cause of dwarfism accelerated children’s growth in a pivotal ...

Digital therapeutics developer Big Health announced Thursday that it has raised $23.7 million from notable investors betting ...

Vinay Prasad is tightening the screws at the FDA, overruling staff and signaling a tougher stance on vaccines and gene ...

Today, we’ve got a ton of updates including news about venture capital funding, telehealth policy, the government’s progress ...

Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.